Dose-Dependent Anti-Inflammatory and Neuroprotective Effects of an ανβ3 Integrin-Binding Peptide
Table 2
Histopathological analysis of demyelination damage in spinal cord (S) and brain cortex (B) of C16 dose dependent treated group.
2 weeks
Control 2 w
C16 0.5 mg 2 w (Low dose group)
C16 1 mg 2 w
C16 2 mg 2 w
Spinal cord
( versus control*)
( versus control*; versus low dose group#)
( versus control*; versus low dose$)
Brain cortex
( versus control*)
( versus control*; versus low dose group#)
( versus control*; versus low dose$)
8 weeks
Control 8 w
C16 0.5 mg 8 w
C16 1 mg 8 w
C16 2 mg 8 w
Spinal cord
( versus control*)
( versus control*; versus low dose group#)
( versus control*; versus low dose$)
Brain cortex
( versus control*)
( versus control*; versus low dose group#)
( versus control*; versus low dose$)
Data is presented as Mean ± SD. was considered statistically significant compared with the control, compared with low dose (0.5 mg) C16 treatment group, and compared with low dose (0.05 mg) C16 treatment group.